MIRM Simply Wall St. 4 days ago A Look At Mirum Pharmaceuticals (MIRM) Valuation After Volatile Trading On Common Stock Offering News
MIRM MT Newswires 6 days ago RBC Lowers Price Target on Mirum Pharmaceuticals to $128 From $130, Keeps Outperform Rating
MIRM MT Newswires 6 days ago Morgan Stanley Raises Price Target on Mirum Pharmaceuticals to $130 From $123, Keeps Overweight Rating
MIRM GuruFocus.com 6 days ago Mirum Pharmaceuticals Inc (MIRM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ...
MIRM Zacks 7 days ago Mirum Pharmaceuticals (MIRM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
